Reasons for prolonged time for diagnostic workup for stage I-II lung cancer and estimated effect of applying an optimized pathway for diagnostic procedures
Open Access
- 18 September 2019
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 19 (1) , 1-9
Abstract
Background: Minimizing the time until start of cancer treatment is a political goal. In Norway, the target time for lung cancer is 42 days. The aim of this study was to identify reasons for delays and estimate the effect on the timelines when applying an optimal diagnostic pathway. Methods: Retrospective review of medical records of lung cancer patients, with stage I-II at baseline CT, receiving curative treatment (n = 100) at a regional cancer center in Norway. Results: Only 40% started treatment within 42 days. The most important delays were late referral to PET CT (n = 27) and exercise test (n = 16); repeated diagnostic procedures because bronchoscopy failed (n = 15); and need for further investigations after PET CT (n = 11). The time from referral to PET CT until the final report was 20.5 days in median. Applying current waiting time for PET CT (≤7 days), 48% would have started treatment within 42 days (p = 0.254). “Optimal pathway” was defined as 1) referral to PET CT and exercise test immediately after the CT scan and hospital visit, 2) tumor board discussion to decide diagnostic strategy and treatment, 3) referral to surgery or curative radiotherapy, 4) tissue sampling while waiting to start treatment. Applying the optimal pathway, current waiting time for PET CT and observed waiting times for the other procedures, 80% of patients could have started treatment within 42 days (p < 0.001), and the number of tissue sampling procedures could have been reduced from 112 to 92 (− 16%). Conclusion: Changing the sequence of investigations would significantly reduce the time until start of treatment in curative lung cancer patients at our hospital and reduce the resources needed.Keywords
Funding Information
- St. Olavs Hospital Universitetssykehuset i Trondheim
This publication has 41 references indexed in Scilit:
- Medical complexity and time to lung cancer treatment – a three-year retrospective chart reviewBMC Health Services Research, 2017
- Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage studyBritish Journal of Cancer, 2014
- The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancerRadiotherapy and Oncology, 2013
- Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians—A national Danish projectHealth Policy, 2012
- Progression of Non–Small-Cell Lung Cancer During the Interval Before Stereotactic Body RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Cancer patients' concerns regarding access to cancer care: perceived impact of waiting times along the diagnosis and treatment journeyEuropean Journal of Cancer Care, 2011
- Rapid Disease Progression With Delay in Treatment of Non–Small-Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Delay in diagnosis: the experience in DenmarkBritish Journal of Cancer, 2009
- The 2-week wait for suspected cancer: time for a rethink?2005
- Under utilisation of the 2-week wait initiative for lung cancer by primary care and its effect on the urgent referral pathwayBritish Journal of Cancer, 2005